{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:59:46Z","timestamp":1777575586450,"version":"3.51.4"},"reference-count":20,"publisher":"S. Karger AG","issue":"2","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney Dis"],"published-print":{"date-parts":[[2020]]},"abstract":"<jats:p>&lt;b&gt;&lt;i&gt;Introduction:&lt;\/i&gt;&lt;\/b&gt; Minimal change disease (MCD) and primary focal segmental glomerulosclerosis (FSGS) are representative podocyte diseases. The clinical cause of MCD and FSGS has not been clearly elucidated yet. However, it is important to distinguish MCD and FSGS because their prognoses and responses to treatment are quite different. &lt;b&gt;&lt;i&gt;Objective:&lt;\/i&gt;&lt;\/b&gt; This study aimed to examine whether parietal epithelial cell (PEC) marker and repeat biopsy are useful for diagnosing primary FSGS. &lt;b&gt;&lt;i&gt;Methods:&lt;\/i&gt;&lt;\/b&gt; Clinicopathological features of 17 patients with the nephrotic syndrome, who underwent kidney biopsy \u22652 times from 1975 to 2017, and had MCD or FSGS were analyzed using PAX8. We defined patients with PAX8+ cells as PAX8+ and the remainder as PAX8\u2013 patients. Three cases of sample insufficiency and 1 non-steroid-resistant or frequently relapsing case indicated for repeat biopsy were excluded. &lt;b&gt;&lt;i&gt;Results:&lt;\/i&gt;&lt;\/b&gt; Among the 13 patients studied, 4 were PAX8+ and 9 were PAX8\u2013 (median age: 41 and 46 years, \u00adrespectively, at first biopsy). PAX8+ and PAX8\u2013 patients showed no significant differences in clinical data and histological diagnosis except for a significant difference in histological diagnosis at the second biopsy. The number of PAX8+ patients increased to 6. Unlike the first biopsy results, FSGS was present in 5 of 6 (83.3%) PAX8+ patients; MCD occurred in all 7 (100%) PAX8\u2013 patients. Three of 6 (50.0%) PAX8+ patients undergoing repeat biopsy were steroid resistant; no (0%) PAX8\u2013 patient was steroid resistant. All cases of final FSGS diagnosis were PAX8+ at the first or second biopsy. Only 1 PAX8+ MCD patient was steroid resistant. All PAX8\u2013 MCD patients were frequently relapsing. &lt;b&gt;&lt;i&gt;Conclusions:&lt;\/i&gt;&lt;\/b&gt; More PAX8+ patients were diagnosed with FSGS than PAX8\u2013 patients. Clinical presentation of MCD in PAX8\u2013 patients was frequently relapsing. PEC marker staining in patients with the nephrotic syndrome, e.g., MCD, may help to diagnose FSGS.<\/jats:p>","DOI":"10.1159\/000505125","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T22:00:33Z","timestamp":1580508033000},"page":"119-124","source":"Crossref","is-referenced-by-count":9,"title":["Morphological Features of Minimal Change Disease and Focal Segmental Glomerulosclerosis Using Repeat Biopsy and Parietal Epithelial Cell Marker"],"prefix":"10.1159","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5536-1741","authenticated-orcid":false,"given":"Tomo","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Kohatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiika","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yahagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiharu","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naohiko","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayuri","family":"Shirai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junki","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yugo","family":"Shibagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2020,1,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1106556"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2013.48"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00228.2013"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10571011"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2014.08.007"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-015-1216-x"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1202500"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2411"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2016.147"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000045609"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5414\/CNP60315"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(96)90157-2"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000358334"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/08860220600840165"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60541-9"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1630-y"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000360908"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.02840313"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfp500"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005020142"}],"container-title":["Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/505125","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/505125","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T16:17:35Z","timestamp":1745425055000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000505125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,12]]},"published-print":{"date-parts":[[2020,4,8]]}},"URL":"https:\/\/doi.org\/10.1159\/000505125","archive":["Portico"],"relation":{},"ISSN":["2296-9381","2296-9357"],"issn-type":[{"value":"2296-9381","type":"print"},{"value":"2296-9357","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]}}}